We are live on ! Find out more
OIMU

Osmosis Investment Management UK Portfolio holdings

AUM $2.15B
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.72B
AUM Growth
-$243M
Cap. Flow
+$7.17M
Cap. Flow %
0.19%
Top 10 Hldgs %
33.86%
Holding
499
New
131
Increased
145
Reduced
180
Closed
43

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$38.4M
2
ADI icon
Analog Devices
ADI
+$32.8M
3
MU icon
Micron Technology
MU
+$19.2M
4
SO icon
Southern Company
SO
+$18.7M
5
MDT icon
Medtronic
MDT
+$18M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$24.3M
2
NVDA icon
NVIDIA
NVDA
+$23.2M
3
AAPL icon
Apple
AAPL
+$21.2M
4
AVGO icon
Broadcom
AVGO
+$20.4M
5
LIN icon
Linde
LIN
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 32.67%
2 Financials 13.53%
3 Healthcare 11.84%
4 Communication Services 10.01%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLE icon
426
Allegion
ALLE
$13.5B
$328K 0.01%
+2,255
New +$360K
HWM icon
427
Howmet Aerospace
HWM
$106B
$327K 0.01%
+1,421
New +$331K
TEL icon
428
TE Connectivity
TEL
$58.8B
$319K 0.01%
+1,527
New +$337K
DVN icon
429
Devon Energy
DVN
$51.5B
$316K 0.01%
+6,288
New +$270K
CL icon
430
Colgate-Palmolive
CL
$72.9B
$315K 0.01%
+3,694
New +$329K
NVMI
431
Nova
NVMI
$11.6B
$309K 0.01%
+720
New +$317K
CSX icon
432
CSX Corp
CSX
$95.2B
$301K 0.01%
+7,329
New +$287K
NKE icon
433
Nike
NKE
$58.1B
$300K 0.01%
+5,684
New +$345K
ZBRA icon
434
Zebra Technologies
ZBRA
$17.2B
$297K 0.01%
+1,422
New +$334K
GEN icon
435
Gen Digital
GEN
$18.4B
$297K 0.01%
15,747
-11,431
-42% -$265K
NBIX icon
436
Neurocrine Biosciences
NBIX
$15.8B
$294K 0.01%
+2,228
New +$296K
OKE icon
437
Oneok
OKE
$60.1B
$289K 0.01%
+3,198
New +$263K
TRP icon
438
TC Energy
TRP
$64.6B
$280K 0.01%
+4,451
New +$268K
OKTA icon
439
Okta
OKTA
$29.4B
$279K 0.01%
3,549
-5,376
-60% -$446K
TRGP icon
440
Targa Resources
TRGP
$62B
$274K 0.01%
+1,093
New +$237K
SRE icon
441
Sempra
SRE
$56.5B
$263K 0.01%
+2,702
New +$247K
GM icon
442
General Motors
GM
$76B
$261K 0.01%
+3,510
New +$279K
GLPI icon
443
Gaming and Leisure Properties
GLPI
$12.4B
$246K 0.01%
5,538
-2,389
-30% -$111K
MAR icon
444
Marriott International
MAR
$92.3B
$244K 0.01%
+746
New +$245K
URI icon
445
United Rentals
URI
$63.5B
$237K 0.01%
+325
New +$273K
ZTS icon
446
Zoetis
ZTS
$31.6B
$233K 0.01%
+1,967
New +$243K
MMM icon
447
3M
MMM
$90.7B
$232K 0.01%
+1,596
New +$254K
ADSK icon
448
Autodesk
ADSK
$54.7B
$231K 0.01%
+966
New +$243K
RIVN icon
449
Rivian
RIVN
$23.2B
$228K 0.01%
+15,140
New +$242K
CP icon
450
Canadian Pacific Kansas City
CP
$82.1B
$224K 0.01%
+2,845
New +$225K

Similar funds

Osmosis Investment Management UK's Q1 2026 Portfolio in Review

As of Q1 2026, Osmosis Investment Management UK held 499 positions worth $3.72B, down 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Osmosis Investment Management UK's Q1 2026 filing shows 131 new, 145 increased, 180 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 199,294 shares worth $38.6M. The largest sale was Elevance Health, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.

  • Osmosis Investment Management UK's largest Q1 2026 buy was AstraZeneca: 199,294 shares worth $38.6M.
  • Osmosis Investment Management UK added most to Southern Company in Q1 2026, an estimated $18.7M increase.
  • Osmosis Investment Management UK's biggest Q1 2026 reduction was Elevance Health, cutting an estimated $24.3M.
  • Osmosis Investment Management UK fully exited Fortinet in Q1 2026, selling an estimated $16.1M.
  • Osmosis Investment Management UK's ten largest holdings make up 34% of its $3.72B portfolio in Q1 2026.
  • Osmosis Investment Management UK opened 131 new positions and closed 43 in Q1 2026.
  • Osmosis Investment Management UK's portfolio value fell 6.1% quarter-over-quarter to $3.72B.

Based on Osmosis Investment Management UK's 13F filing for Q1 2026, filed 14 May 2026.